Proteus Biomedical has received CE Mark approval from the European Union to bring to market the firm’s Raisin ingestible drug sensors and monitoring system. When a patient swallows tablets that have individually tagged beacons on them, a sensor can automatically record the precise time and basic vital signs of the patient at that time. The system allows physicians to get a better picture of how a patient responds to a given medication.
Read more here.
chiaruscuru liked this
chiaruscuru reblogged this from dvint1
loscisnesmorados liked this
richardsonshe liked this
making462 liked this
spring909 liked this
gomode832 liked this
dvint1 reblogged this from sparksdo
passgo893 liked this
today9201 liked this
dvint1 liked this
sparksdo reblogged this from bearfarming
bearfarming reblogged this from calmly-chaotic
calmly-chaotic posted this
